You are viewing an expired study

This study is not currently recruiting Study Participants on If you would like to find active studies please browse nearby listings below.

Click here to view additional nearby studies or search for clinical trials.

Rochester, New York 14642

  • Breast Cancer, Metastatic


The purpose of this study is to evaluate whether radiosurgery, along with standard chemotherapy, immunotherapy (the treatment of cancer by modulating the immune system and immune response), or hormonal therapy, affects the quality and length of life. The standard therapy is surgery, radiation therapy, or chemotherapy alone or in any combination. A second purpose of this study is to determine if the levels of a special type of protein (called cytokines) found in the blood are related to the quality of life while on this treatment.

Study summary:

Before treatment begins, you will have a physical exam and blood tests. Physical evaluations and blood tests will be done each week while you are receiving treatment, and at follow-up visits. You will be seen for follow-up evaluations 4 weeks after treatment is completed, and every three months thereafter. You will be asked to fill out a Quality of Life questionnaire, which should take 5-10 minutes to complete. This will be done prior to treatment and at your follow-up visits. You will receive high dose radiation therapy directed at the site of metastasis. This treatment will be given once a day, 5 times a week (Monday through Friday) for one to four weeks depending on the location and size of the disease to be treated.


Inclusion Criteria: - Age: no limit - Karnofsky performance status (KPS) ≥ 70 - No more than 5 metastatic sites involving one or more different organs (liver, lung or bone). - The size of the lesion must be such that it can be safely treated to sterilizing radiation doses according to the rules in the protocol. - Previously treated lesions are not eligible unless the prescribed dose can be safely delivered. - Concurrent therapy is allowed and recommended. The chemotherapy protocol type and schedule are at the discretion of the medical oncologist. - Informed consent must be obtained. - Pregnancy test must be negative for women of child bearing potential Exclusion Criteria: - Inability of patient to be followed longitudinally as specified by protocol. - Technical inability to achieve required dose based on safe dose constraints required for radiosurgery. - Women who are pregnant or nursing. - Failure to meet requirements in Inclusion Criteria - Contraindications to radiation.



Primary Contact:

Principal Investigator
Hong Zhang, MD
University of Rochester

Backup Contact:


Location Contact:

Rochester, New York 14642
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: April 07, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.